DJIA 17,976.31 263.65 1.49%
NASDAQ 4,947.44 0.00 0.00%
S&P 500 2,086.24 25.22 1.22%
market minute promo

PHARMACYCLICS, INC. (NASDAQ: PCYC)



company name or ticker

Pharmacyclics, BioMarin, And Incyte: A Quick Screen

New ETF From BlackRock And Edelman

New ETF From BlackRock And Edelman

3 Stocks Reiterated As A Hold: PCYC, LNKD, PM

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

Better Dividend Stock: AbbVie or Gilead Sciences, Inc.?

AbbVie and Gilead are two closely followed dividend stocks in the healthcare sector. Which one offers investors the better long-term prospects moving forward?

Confessions of a Value Investor Stuck in a High-Growth Industry

It's OK to buy premium-priced biotechs.

The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releas

The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releases

Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog

Pharmacyclics' Imbruvica Encourages in a Phase III Study - Analyst Blog

See More Articles...